This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Standalone Q2 FY27 revenue up 14%, profit after tax up 45% to Rs 15.40 crore
GPTHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.1 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Standalone Q2 FY27 revenue was Rs 135.62 crore versus Rs 118.91 crore in Q2 FY26, and profit after tax was Rs 15.40 crore versus Rs 10.60 crore. Profit rose 45%; the margin before other income, interest, depreciation and tax rose from 18.53% to 19.82%. Standalone H1 FY27 revenue was Rs 261.83 crore and profit after tax Rs 28.13 crore. Cash generated from operations was Rs 34.23 crore. A 10% interim dividend of Rs 1 per share was declared.
Positive for shareholders: Q2 revenue and profit after tax rose, profitability improved, and a 10% interim dividend provides a cash return.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹135.6 Cr | ₹118.9 Cr | +14.1% |
| Operating profit | ₹17.73 Cr | ₹13.73 Cr | +29.1% |
| Profit after tax | ₹15.40 Cr | ₹10.60 Cr | +45.2% |
| EBITDA margin | 19.8% | 19.1% | +0.7 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.